Janus kinase 3

Janus Kinase 3

Diagram of JAK3 signal transduction pathway

Janus kinase 3 (JAK3) is a member of the Janus kinase family of intracellular, non-receptor tyrosine kinases. JAK3 is primarily expressed in hematopoietic cells and plays a crucial role in the signaling pathways of various cytokine receptors.

Structure

JAK3, like other members of the Janus kinase family, contains several important domains: a Ferm domain, an SH2-like domain, a pseudokinase domain, and a kinase domain. The kinase domain is responsible for the enzyme's catalytic activity, while the pseudokinase domain regulates the kinase activity.

Function

JAK3 is involved in the signaling of type I and type II cytokine receptors, which include receptors for interleukins such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. These cytokines are critical for the development and function of the immune system. JAK3 associates with the common gamma chain (_c) of these cytokine receptors and, upon cytokine binding, becomes activated through trans-phosphorylation.

Signal Transduction

Upon activation, JAK3 phosphorylates specific tyrosine residues on the receptor, creating docking sites for signal transducer and activator of transcription (STAT) proteins. These STAT proteins are then phosphorylated by JAK3, dimerize, and translocate to the cell nucleus where they act as transcription factors to modulate gene expression.

Clinical Significance

Mutations in the JAK3 gene can lead to severe combined immunodeficiency (SCID), a condition characterized by the absence of functional T and NK cells. JAK3 inhibitors are being explored as potential treatments for various autoimmune diseases and cancer, due to their ability to modulate immune responses.

Related Pages

• Janus kinase
• Signal transducer and activator of transcription
• Cytokine receptor
• Severe combined immunodeficiency